Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics.

Slides:

Advertisements

Similar presentations

Postmarket Surveillance of Medical Device Adverse Events Hesha Jani Duggirala, PhD Epidemiology Branch Division of Postmarket Surveillance Office of Surveillance.

Advertisements

Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010

Overview of FDA Device Regulations

Susan Best, NRL, Australia WHO post-market surveillance for In Vitro Diagnostic Devices (IVD)

© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.

Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.

Pharmacovigilance and Risk Management Chapter 17.

Medical Devices Approval Process

Field Investigators: ADE Detectives. Section One Introduction to the Team and Their Roles.

1 Authorised Representative Licensing Presented By: Eng. Abdullah S. Al Dobaib Registration and Licensing Executive Department,MDS 8/9/2015 2:53 PM.

CE marking Catriona Blake Team Manager, Imaging, acute and community care.

Federal Agency for Medecines and Health Products Federal Agency for Medicines and Health Products (FAMHP) FAMHP/DLT/ Lambot Damien Materiovigilance.

William B Munier, MD, MBA, Director Center for Quality Improvement and Patient Safety Agency for Healthcare Research and Quality AHRQ Annual Conference.

Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.

FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

Canada Consumer Product Safety Act An Overview Graham Stewart Health Canada.

Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.

Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 

Challenges to Indian Multinational Cos. P. M. Kelkar 18 th March, 2006 Thorale Bajirao Peshwe Sabhagruha, Thane.

A royal decree was issued on Feb.13, 2007 assigned the responsibility for regulating medical devices, in vitro diagnostic devices, prescription eye glasses,

What is Food Recall A food recall is a voluntary action by a manufacturer or distributor to protect the public from products that may cause health problems.

What Makes a Good Medical Device Adverse Event Report?

Health and Safety Executive Health and Safety Executive Regulation of distribution and farm level uses Paul Adamson & Helena Cooke.

Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.

The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.

INTRODUCTION TO RA.

Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.

How to Register A Foreign Medical Device. SFDA Approval Documents Preparation Translation Create a Chinese Registration Standard Safety Testing in an.

Implementation of the Proposed Canada Consumer Product Safety Act (Bill C-6) Mandatory Reporting Health Canada ICPHSO 2009, Toronto.

MDS Statistics for the third Quarter of the year 2012.

Rules for Supporting Part 803 and Part 806 Decision Making Page 1 Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports.

Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.

Practical Implications of Electrical Product Safety Regulation in Ontario International Consumer Product Health and Safety Organization Sixth International.

FDA Regulatory and Compliance Symposium

Investigational Devices and Humanitarian Use Devices June 2007.

Center for Devices and Radiological Health U. S. Department of Health and Human Services Al Taylor Acting Chief, Medical Electronics Branch Office of Science.

The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.

Update: Inspection Demonstration Program Helen J. Barr, M.D. Deputy Director, Division of Mammography Quality and Radiation Programs.

FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,

Government Agencies. World Health Organization  Sponsored by United Nations  Investigates serious diseases & health issues across the world.

PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.

Complaint and recall 1. Title 21--food and drugs Chapter I- food and drug administration department of health and human services Subchapter A- General.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.

CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.

COMPLAINT HANDLING PROCESS. DEFINITION OF A COMPLAINT Any written, electronic, or oral communication that alleges deficiencies of a distributed device.

THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.

NANCY CHOBIN, RN, AAS, ACSP, CSPM, CFER CHOBIN & ASSOCIATES CONSULTING HOT TOPICS IN STERILIZATION AND DISINFECTION.

Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.

Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)

November 6, 2013 Purchasing Controls & Supplier Quality Best Practices Beyond Compliance for the Medical Device Industry AdvaMed 2013 Bernie Liebler Technology.

Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.

KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.

RAC Regulatory Affairs Certification

ANNUAL PRODUCT REVIEW Patchara Kootiratrakarn Independent consultant.

The Working Group on Medical Measurements The 23rd Forum Meeting

U.S. FDA Center for Devices and Radiological Health Update

Unit for Medical Systems and Devices at Ministry of Health

The Information Professional’s Role in Product Safety

How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.

The Current PMA Requirements

REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.

Combination products The paradigm shift

FDA Resources and Meetings

Linda M. Chatwin, Esq. RAC Business Manager, UL LLC

Ministry of Health Malaysia VOLUNTARY REGISTRATION FOR MEDICAL DEVICES ESTABLISHMENTS MeDVER Ministry of Health Malaysia.

Tobey Clark, Director*, Burlington USA

Compounded Drugs and Lack of Premarket FDA-Approval

Presentation transcript:

Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics

Medical Devices Life Cycle Conception and Design Manufacture Packaging Labelling Advertising Sale Use Disposal Pre-market On-market Post-market

Postmarket Surveillance Collection of information on the quality, safety and performance of medical devices; Assessment / Evaluation; Investigation; and Reaction to data on medical devices performance after placed on the market.

Postmarket Surveillance Inputs 1.Healthcare facilities & public complains. 2. Int’l and local establishments (Manufacturers/AR, Distributors ). 3. Other int’l regulatory authorities. 4. NCMDR membership ( NCAR / SADS)

What should be Reported? Any malfunction or deterioration in the characteristics and/or performance of a medical device, as well as any inadequacy in the labeling or the instructions for use, which has led, or might have led, to the death of a patient, user or third person, or to a serious deterioration in the state of health of a patient, user or third person. hat W W

Adverse events that result in unanticipated death or unanticipated serious injury or represent a serious public health threat must be reported immediately by the manufacturer, authorized representative, importer or distributor. All other reportable events must be reported as soon as possible by the manufacturer, authorized representative, importer or distributor following the date of awareness of the event (according to GHTF jurisdiction issuing market authorization). When to report ? W W hen

Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Maintain traceability system for surveillance purposes. Report to SFDA any FSN/ adverse event might become aware of its occurrence online, through the following link: ( Provide list of: - related customer/s planned to notified (hospitals, clinics, public…etc ) and - affected medical devices placed on KSA market as well as placed in services. Submit a planed action for reviewing & approval by SFDA-NCMDR.

Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Cont… Submit determinant date for implementing agreed on action plan & closing the FSN. Any related communication to FSN with concerned customer/s shall approved by SFDA before send out. Periodic submission of progress report concerning the FSN approved action. Effectiveness checks reports, showing action plan implemented and FSN’s closure. Determine depth of the FSN’s (The FSN’s may affect other party/ies in the supply chain e.g. Lay person, retail and the wholesale.etc)

MDS - IR7 MDS - IR7

Surveillance & Biometrics Executive Department Statistics

No. Of FSCA from 2008 to (22/11/2011) by source: Source Total Percentage ECRI % FDA % MHRA % NCAR % NCMDR % BfArM % Total %

No. Of Adverse event from 2008 to (22/11/2011) by years: Source Total NCMDR

Total FSCA where corrective actions implemented & closed are equal to 4083 which %57 of the total. Total FSCA and adverse events reflect unrecognized distributors are equal to 1541 which 21.6% of the total. Total FSCA and adverse events that transferred to compliance & enforcement are equal to 112 which 0.1% of the total ( up to date).

SBED is communicating with 221 healthcare facilities 18 Directorates health affairs Total number of SBED-Officers representing healthcare facilities and health regional agencies representatives 261 Biomedical Engineers Nurses Total number of SBED-Officers for Establishments within KSA 297

Accessing the National Center for Medical Devices Reporting SFDA

How to access NCMDR? Step1. Go to Step2. Click on Medical Devices iconStep3. Click on MDES icon

Step 4. Click on NCMDR icon How to access NCMDR?...cont

Challenges / areas of improvement 1. Limited No. of establishments that report reportable adverse events to SFDA through NCMDR. 2. Limited No. of registered establishments officers in the NCMDR ( Total number of the registered officers in the system 297 while registered establishments in the MDNR are 1200 ?? ). 3. Slowness in response from the establishments on their medical devices subjected to FSN they marketed in KSA.

Challenges / areas of improvement …Cont. Challenges / areas of improvement …Cont. 5.Inaccurate information in official letters issued by establishments on their planned corrective action. 4. Non-complying with SFDA requirements during follow up communication with the establishments.

Thank You